Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

What happened today? It is going back to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Amatuer17 Member Profile
 
Followed By 71
Posts 11,930
Boards Moderated 0
Alias Born 04/03/14
160x600 placeholder
Oramed's Phase 2 Oral Insulin NASH Trial Reaches Over 50% Enrollment PR Newswire (US) - 9/15/2021 8:10:00 AM
Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire (US) - 9/9/2021 8:25:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/2/2021 4:50:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 4:49:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 4:44:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2021 8:26:20 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/1/2021 8:17:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2021 4:16:13 PM
Oramed Reaches 25% Enrollment in Its Second of Two Concurrent Phase 3 Oral Insulin Trials PR Newswire (US) - 8/24/2021 8:25:00 AM
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism PR Newswire (US) - 8/16/2021 8:25:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 8/13/2021 5:06:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2021 5:16:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2021 5:15:53 PM
Oramed to Present at Canaccord Genuity's 41st Annual Growth Conference PR Newswire (US) - 8/9/2021 8:40:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2021 4:02:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 7:02:41 AM
Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021 PR Newswire (US) - 8/5/2021 6:40:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/4/2021 4:31:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2021 4:31:14 PM
Oramed Pharmaceuticals names chief commercial officer Seeking Alpha - 7/29/2021 8:31:39 AM
Oramed Pharmaceuticals Appoints Chief Commercial Officer PR Newswire (US) - 7/29/2021 8:25:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 7/28/2021 4:31:41 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/27/2021 6:04:30 AM
Oramed subsidiary to start clinical trials for its oral COVID-19 vaccine candidate Seeking Alpha - 7/21/2021 9:28:25 AM
Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial PR Newswire (US) - 7/21/2021 8:25:00 AM
Amatuer17   Tuesday, 04/13/21 01:58:02 PM
Re: None
Post # of 1123 
What happened today? It is going back to its $7-8 range

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences